CarepathRx Acquires Chartwell MSO; UPMC Becomes Strategic Investor

December 1, 2020

CarepathRx will acquire the management services organization that operates UPMC's Chartwell specialty pharmacy and home infusion business, while UPMC will take a strategic equity stake in CarepathRx. The transaction (reported at approximately $400 million) expands CarepathRx's specialty pharmacy and home-infusion capabilities and creates a long-term partnership between the companies.

Buyers
CarepathRx, UPMC
Targets
Chartwell management services organization (Chartwell MSO)
Sellers
Chartwell (UPMC subsidiary)
Location
Pennsylvania, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.